Nutrition and bronchopulmonary dysplasia;Nutrition et dysplasie bronchopulmonaire

Archives de Pediatrie

Volumn 11, Issue 3, 2004, Pages 234-239

  Bott, L ^a   Beghin L ^a   Pierrat, V ^a   Thumerelle, C ^a   Gottrand, F ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Airway obstruction; Bronchial hyperreactivity; Bronchopulmonary dysplasia; Child; Croissance staturopond rale; Distension bronchique; Dysplasie bronchopulmonaire; Growth; Hyperactivit bronchique; Nutrition; Obstruction bronchique

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; GLUTAMINE; INOSITOL; POLYUNSATURATED FATTY ACID; RETINOL; SURFACTANT;

AIRWAY OBSTRUCTION; BRAIN DEVELOPMENT; BRONCHUS HYPERREACTIVITY; CALORIE; DIET SUPPLEMENTATION; GROWTH CURVE; HUMAN; LONG TERM CARE; LUNG DEVELOPMENT; LUNG DYSPLASIA; MALNUTRITION; NUTRITION; NUTRITIONAL STATUS; PERINATAL PERIOD; PNEUMONIA; PREMATURITY; REVIEW;

EID: 1442287288     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2003.11.008     Document Type: Short Survey

References (59)

1. Cambonie G., Counil F. Devenir respiratoire des prématurés: évolution jusqu'à l'âge de deux ans. Arch Pédiatr. 9:(Suppl 2):2002;74s-77s.
2. Epipage, Truffert P., Maillard F., Burguet A. Mortalité pulmonaire du grand prématuré: incidence et prise en charge. Cohorte Epipage 1997. Collet M., Treisser A. Médecine périnatale. 2001;175-182 Arnette, Paris.
3. Northway W.H. Jr, Rosan R.C., Porter D.Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 276:1967;357-368.
4. Shennan A.T., Dunn M.S., Ohlsson A., Lennox K., Hoskins E.M. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 82:1988;527-532.
5. Davis P.G., Thorpe K., Roberts R., Schmidt B., Doyle L.W., Kirpalani H. Evaluating "old" definitions for the "new" bronchopulmonary dysplasia. J Pediatr. 140:2002;555-560.
6. Jobe A.H., Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev. 53:1998;81-94.
7. Rigourd V. La croissance pulmonaire. Arch Pédiatr. 9:(Suppl 4):2002;438s-443s.
8. Jobe A.H. The new BPD: an arrest of lung development. Pediatr Res. 46:1999;641-643.
9. Jobe A.H., Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 163:2001;1723-1729.
10. Jobe A.H., Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res. 2:2001;27-32.
11. Davis J.M. Role of oxidant injury in the pathogenesis of neonatal lung disease. Acta Paediatr suppl. 9:2002;23-25.
12. Farrell P.A., Fiascone J.M. Bronchopulmonary dysplasia in the 1990s: a review for the pediatrician. Curr Probl Pediatr. 27:1997;129-163.
13. Perl A.K., Whitsett J.A. Molecular mechanisms controlling lung morphogenesis. Clin Genet. 56:1999;14-27.
14. Ballard P.L. Scientific rationale for the use of antenatal glucocorticoids to promote fetal development. Pediatr Rev. 1:2000;E83-E90.
15. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol. 18:2001;1-9.
16. Olsen I.E., Richardson D.K., Schmid C.H., Ausman L.M., Dwyer J.T. Intersite differences in weight growth velocity of extremely premature infants. Pediatrics. 110:2002;1125-1132.
17. Kerr J.S., Riley D.J., Lanza-Jacoby S., Berg R.A., Spilker H.C., Yu S.Y., et al. Nutritional emphysema in the rat. Influence of protein depletion and impaired lung growth. Am Rev Respir Dis. 131:1985;644-650.
18. Guarner V., Tordet C., Bourbon J.R. Effects of maternal protein-calorie malnutrition on the phospholipid composition of surfactant isolated from fetal and neonatal rat lungs. Compensation by inositol and lipid supplementation. Pediatr Res. 31:1992;629-635.
19. Darlow B.A., Cust A.E., Donoghue D.A. Improved outcomes for very low birth weight infants: evidence from New Zealand national population based data. Arch Dis Child Fetal Neonatal Ed. 88:2003;F23-F28.
20. Lorenz J.M. The outcome of extreme prematurity. Semin Perinatol. 25:2001;348-359.
21. Tommiska V., Heinonen K., Kero P., Pokela M.L., Tammela O., Järvenpäa A.L., et al. A national two year follow up study of extremely low birthweight infants born in 1996-1997. Arch Dis Child Fetal Neonatal Ed. 88:2003;F29-F35.
22. Vrlenich L.A., Bozynski M.E.A., Shyr Y., Schork M.A., Roloff D.W., McCormick M.C. The effect of bronchopulmonary dysplasia on growth at school age. Pediatrics. 95:1995;855-859.
23. Karila C., de Blic J. Évolution de l'enfance (après 3 ans) à l'âge adulte. Arch Pédiatr. 9:(Suppl 2):2002;78S-79S.
24. Klein C.J. Nutrient requirements for preterm infant formulas. The American Society for Nutritional Sciences. J Nutr. 132:2002;1395S-1577S.
25. Casey P.H., Kraemer H.C., Bernbaum J., Yogman M.W., Sells J.C. Growth status and growth rates of a varied sample of low birth weight, preterm infants: a longitudinal cohort from birth to three years of age. J Pediatr. 119:1991;599-605.
26. Hankard R. Improving nutritional support in chronic lung disease. J Pediatr Gastroenterol Nutr. 36:2003;432-433.
27. Tyson J.E., Wright L.L., Oh W., Kennedy K.A., Mele L., Ehrenkranz R.A., et al. Vitamin A supplementation for extremely-low-birth-weight infants: national institute of child health and human development neonatal research network. N Engl J Med. 340:1999;1962-1968.
28. Kalenga M., Tschanz S.A., Burri P.H. Protein deficiency and the growing rat lungs. Nutritional findings and related lung volumes. Pediatr Res. 37:1995;783-788.
29. Schwartz J. Role of polyunsaturated fatty acids in lung disease. Am J Clin Nutr. 71:(1 Suppl):2000;393S-396S.
30. Forsyth J.S., Willats P., Agostini C., Bissenden J., Casaer P., Boehm G. Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow-up of a randomised controlled trial. BMJ. 326:2003;953.
31. Meisels S.J., Plunkett J.W., Roloff D.W., Pasick P.L., Stiefel G.S. Growth and development of preterm infants with respiratory distress syndrome and bronchopulmonary dysplasia. Pediatrics. 77:1986;345-352.
32. Guémas I. Suivi des enfants atteints de dysplasie bronchopulmonaire. 2003;Thèse de médecine, Lille.
33. Tammela O.K.T., Koivisto M.E. A 1-year follow-up birth weight infants with and without bronchopulmonary dysplasia: health, growth, clinical lung disease, cardiovascular and neurological sequelae. Early Hum Dev. 30:1992;109-120.
34. Bozynski M.H.A., Albert J.M., Vasan U., Nelson M.N., Zak L.K., Naughton P.M. Bronchopulmonary dysplasia and postnatal growth in extremely premature black infants. Early Hum Dev. 21:1990;83-92.
35. Markestad T., Fitzhardinge P.M. Growth and development in children recovering from bronchopulmonary dysplasia. J Pediatr. 98:1981;597-602.
36. Sauve R.S., Singhal N. Long term morbidity of infants with bronchopulmonary dysplasia. Pediatrics. 76:1985;725-733.
37. Brunton J.A., Saigal S., Atkinson S.A. Growth and body composition in infants with bronchopulmonary dysplasia up to three months corrected age: a randomized trial of a high-energy nutrient enriched formula fed after hospital discharge. J Pediatr. 133:1998;340-345.
38. Weiler H.A., Paes B., Shah J.K., Atkinson S.A. Longitudinal assessment of growth and bone mineral acretion in prematurely born infants treated for chronic lung disease with dexamethasone. Early Hum Dev. 47:1997;271-286.
39. Alegret S. Fréquence des facteurs associés à la malnutrition chez l'enfant porteur d'une dysplasie bronchopulmonaire. 2002;Thèse de médecine, Lille.
40. Lucas A., Bishop N.J., King F.J., Cole T.J. Randomised trial of nutrition for preterm infants after discharge. Arch Dis Child. 67:1992;324-327.
41. Franck L., Sosenko I.R.S. Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia. Am Rev Resp Dis. 138:1988;725-729.
42. Atkinson S.A. Special nutritional needs of infants for prevention of and recovery from bronchopulmonary dysplasia. J Nutr. 131:(3):2001;942s-946s.
43. Abrams S.A. Chronic pulmonary insufficiency in children and its effect on growth and development. J Nutr. 131:2001;938s-941s.
44. Clement A. Dysplasie bronchopulmonaire. Rev Mal Resp. 13:1996;243-249.
45. Odièvre M.H., Olivier C. Nutrition et croissance: Synthèse. Arch Pédiatr. 9:(Suppl 4):2002;459s-460s.
46. Atkinson S. Human milk feeding of the micropremie. Clinics Perinatol. 27:2000;235-247.
47. Newell S.J. Enteral feeding of the micropremie. Clin Perinatol. 27:2000;221-234.
48. Boehm G., Bierbach U., Moro G., Minoli I. Limited fat digestion in infants with bronchopulmonary dysplasia. J Pediatr Gastroenterol Nutr. 22:1996;161-166.
49. Lorenz J.M. The outcome of extreme prematurity. Semin Perinatol. 25:2001;348-359.
50. De Meer K., Westerterp K.R., Houwen R.H., Brouwers H.A., Berger R., Okken A. Total energy expenditure in infants with bronchopulmonary dysplasia is associated with respiratory status. Eur J Pediatr. 156:1997;299-304.
51. Huysman W.A., de Ridder M., de Bruin N.C., van Helmond G., Terpstra N., Van Goudoever J.B., et al. Growth and body composition in preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed. 88:2003;F46-F51.
52. Singer L., Martin R.J., Hawkins S.W., Benson-Szekaly L.J., Yamashita T.S., Carlo W.A. Oxygen desaturation complicates feeding in infants with bronchopulmonary dysplasia after discharge. Pediatrics. 90:1992;380-384.
53. Grégoire M.C., Lefebvre F., Glorieux J. Health and development outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia. Pediatrics. 101:1998;856-860.
54. Carlson S.E., Werkman S.H., Peeples J.M., Wilson W.M. Long chain fatty acids and early visual and cognitive development of preterm infants. Eur J Clin Nutr. 48:(Suppl 2):1994;S27-S30.
55. Carlson S.E., Werkman S.H. A randomised trial of visual attention of preterm infants fed docosohexaenoic acid until two months. Lipids. 31:1996;85-90.
56. Martinez M. Tissue levels of polyunsatured fatty acids during early human development. J Pediatr. 120:1992;S129-S138.
57. Guimber D., Michaud L., Storme L., Deschildre A., Turck D., Gottrand F. Gastrostomy in infants with neonatal pulmonary disease. J Pediatr Gastroenterol Nutr. 36:2003;459-463.
58. Peireira G.R., Baumgart S., Bennett M.J., Stallings V.A., Georgieff M.K., Hamosh M., et al. Use of high-fat formula for premature infants with bronchopulmonary dysplasia: metabolic, pulmonary, and nutritional studies. J Pediatr. 124:1994;605-611.
59. Singhal A., Fewtrell M., Cole T.J., Lucas A. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet. 361:2003;1089-1097.